Abbott Park

Abbott Park News

• OraSure In-Home HIV Test Kit Moves Closer to FDA Approval

  Updated 57 minutes ago

  OraSure Technologies Inc. soared the most in three years after U.S. regulatory advisers backed its bid to bring to market the first at-home HIV test that lets people get results without using a doctor or laboratory.

• Abbott to Pay $1.6 Billion to Settle Depakote Drug Allegations

  Abbott Laboratories said it reached an agreement to pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote, the second-largest drug-marketing settlement in U.S. history.

• Human Genome Most Lucrative on Record Biotech Premiums

  Drug companies are in such need of the latest experimental therapies to replace medicines losing patent protection that even a 68 percent takeover premium for Human Genome Sciences Inc. isn’t enough.

• Abbott, Lassonde, Match.com, Apple: Intellectual Property

  Abbott Laboratories, a U.S. health- care company, sued the German drug maker Boehringer AG’s Roxane Laboratories Inc. and accused it of infringing three patents for the HIV drug Norvir.

• 

  Abbott Breakup Plans Are on Target as Profit Tops Estimates

  Abbott Laboratories, splitting into a drugmaker and a diversified health-care business, reported earnings that beat analysts’ estimates and raised its 2012 forecast as sales jumped more than expected for its top product.

• Abbott Reports Two Hepatitis C Relapses in ‘Pilot’ Trial

  Few relapses were reported among patients taking Abbott Laboratories’ experimental hepatitis C treatment, according to a study.

• Abbott’s Humira Wins European Approval for Ulcerative Colitis

  Abbott Laboratories said the European Commission approved its Humira injection for moderately to severely active ulcerative colitis in adults who haven’t responded well to conventional treatment.

• Abbott Sues Boehringer’s Roxane Over Patents for Norvir

  Abbott Laboratories, a U.S. health- care company, sued the German drug maker Boehringer AG’s Roxane Laboratories Inc. and accused it of infringing three patents for the HIV drug Norvir.

• 

  Abbott Hepatitis C Therapy Works After Other Drugs Fail

  Abbott Laboratories’ experimental hepatitis C treatment cured almost half of patients who couldn’t eliminate the virus with therapies now on the market, according to a study that boosted the company’s shares.

• Abbott, Andy Warhol, Glaxo, Clif Bar: Intellectual Property

  Abbott Laboratories sued Watson Pharmaceuticals Inc. in Wilmington, Delaware, federal court for allegedly infringing two patents for its Niaspan cholesterol drug.

Abbott Park Photos

Related Topics

• 

  New York

• 

  Delaware

• 

  Justice Department

• 

  California

Most Popular on Bloomberg

• Facebook Said to Raise Size of IPO to 421 Million Shares

• Facebook’s Saverin May Save $67 Million on U.S. Tax Bill

• Greece Plans for June 17 Vote Under Caretake Government

• Merkel-Hollande Meeting Yields Greece Growth Signal

• Greek President Told Banks Anxious as Deposits Pulled